|
| | Palbociclib-d8 Basic information |
| Product Name: | Palbociclib-d8 | | Synonyms: | Palbociclib-d8;PD 0332991-d8;[2H8]-Palbociclib;6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl-2,2,3,3,5,5,6,6-d8)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one;Palbociclib D8Q: What is
Palbociclib D8 Q: What is the CAS Number of
Palbociclib D8 Q: What is the storage condition of
Palbociclib D8 Q: What are the applications of
Palbociclib D8;*Tramadol Impurity 24 | | CAS: | 1628752-83-9 | | MF: | C24H21D8N7O2 | | MW: | 455.582054224 | | EINECS: | | | Product Categories: | | | Mol File: | 1628752-83-9.mol |  |
| | Palbociclib-d8 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO: Soluble | | form | A solid |
| | Palbociclib-d8 Usage And Synthesis |
| Uses | Palbociclib-d8 is labelled Palbociclib (P139900), an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
| | Palbociclib-d8 Preparation Products And Raw materials |
|
